Table 3.
Aesthetic vs Reconstructive Subgroup Analysis: Systemic Complications per Patient
| Aesthetic (N = 3826) | Reconstructive (N = 2412) | P-value | |
|---|---|---|---|
| Any adverse event | 4.34% (166) | 6.76% (163) | <.0001b |
| DVT or PE | 0.03% (1) | 0.08% (2) | .5635 |
| Pneumothorax | 0.05% (2) | 0.00% (0) | .5256 |
| Bleeding requiring transfusion | 0.03% (1) | 0.08% (2) | .5635 |
| Cardiac complications | 0.00% (0) | 0.08% (2) | .1495 |
| Respiratory complications | 0.03% (1) | 0.08% (2) | .5635 |
| Need for antibiotics | 0.94% (36) | 2.20% (53) | <.0001b |
| Oral | 88.89% (32) | 66.04% (35) | .0229b,a |
| Intravenous | 11.11% (4) | 33.96% (18) | |
| Unplanned ER visit | 0.03% (1) | 0.54% (13) | <.0001b |
| Unplanned hospital admission | 0.16% (6) | 1.04% (25) | <.0001b |
| Unplanned return to OR | 1.57% (60) | 2.11% (51) | .1163 |
Values are % (n). DVT, deep vein thrombosis; ER, emergency room; OR, operating room; PE, pulmonary embolism. aComparison of oral/intravenous distribution between patient cohorts. bStatistically significant.